Trastuzumab [Herceptin; Roche] has received extended approval for the treatment of patients with HER2-positive localised breast cancer in Australia

Source: Inpharma, Volume 1, Number 1535, 2006-04-29 , pp. 22-22(1)

Publisher: Adis International

Keywords: Development-status; Early-breast-cancer, treatment; Product-approvals; Roche; Trastuzumab, therapeutic use

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers